Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments

[1]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[2]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[3]  Richard W. Conners,et al.  Toward a Structural Textural Analyzer Based on Statistical Methods , 1981 .

[4]  Mohan M. Trivedi,et al.  Segmentation of a high-resolution urban scene using texture operators , 1984, Comput. Vis. Graph. Image Process..

[5]  C Nahmias,et al.  A Rostrocaudal Gradient for Aromatic Acid Decarboxylase in the Human Striatum , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[7]  C D Marsden,et al.  Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.

[8]  Erkki Oja,et al.  Detecting texture periodicity from the cooccurrence matrix , 1990, Pattern Recognit. Lett..

[9]  D J Brooks,et al.  Advances in imaging Parkinson's disease. , 1997, Current opinion in neurology.

[10]  I G McKeith,et al.  Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.

[11]  Sung Yong Shin,et al.  Fast determination of textural periodicity using distance matching function , 1999, Pattern Recognit. Lett..

[12]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[13]  E. Tolosa,et al.  Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes , 2004, Movement disorders : official journal of the Movement Disorder Society.

[14]  Perry E Radau,et al.  Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  F. O’Sullivan,et al.  Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome , 2008, Journal of Nuclear Medicine.

[16]  V. Sossi,et al.  Progression of dopaminergic dysfunction in a LRRK2 kindred , 2008, Neurology.

[17]  Issam El-Naqa,et al.  Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..

[18]  V. Sossi,et al.  Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. , 2009, Brain : a journal of neurology.

[19]  Nikolaos Karatzas,et al.  SPECT imaging evaluation in movement disorders: far beyond visual assessment , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  V. Sossi,et al.  Dopamine turnover increases in asymptomatic LRRK2 mutations carriers , 2010, Movement disorders : official journal of the Movement Disorder Society.

[21]  J Nucl Med , 2010 .

[22]  Andreea C. Bostan,et al.  The basal ganglia communicate with the cerebellum , 2010, Proceedings of the National Academy of Sciences.

[23]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[24]  V. Sossi,et al.  Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease. , 2011, Brain : a journal of neurology.

[25]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[26]  Ronald Boellaard,et al.  Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  Jonathan A Disselhorst,et al.  Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET. , 2012, International journal of radiation oncology, biology, physics.

[28]  M. Hatt,et al.  Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.

[29]  Impact of DaTscan™ SPECT Imaging on Clinical Management, Diagnosis, and Confidence of Diagnosis in Patients with Clinically Uncertain Parkinsonian Syndromes: A Prospective 1-Year Follow-Up Study (P03.123) , 2012 .

[30]  John Seibyl,et al.  SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0* , 2012, The Journal of Nuclear Medicine.

[31]  N. Thacker,et al.  Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.

[32]  Susanne Klutmann,et al.  Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Vicky Goh,et al.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[35]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[36]  A. Rahmim,et al.  Novel parametric PET image quantification using texture and shape analysis , 2012, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).

[37]  P. Lambin,et al.  Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability , 2013, Acta oncologica.

[38]  Martin J. McKeown,et al.  Novel spatial analysis method for PET images using 3D moment invariants: Applications to Parkinson's disease , 2013, NeuroImage.

[39]  Xiaoying Tang,et al.  Bayesian Parameter Estimation and Segmentation in the Multi-Atlas Random Orbit Model , 2013, PloS one.

[40]  Joseph O Deasy,et al.  STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  Neda Jahanshad,et al.  Whole-genome analyses of whole-brain data: working within an expanded search space , 2014, Nature Neuroscience.

[43]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[44]  Florent Tixier,et al.  Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non–Small Cell Lung Cancer , 2014, The Journal of Nuclear Medicine.

[45]  Kara M. Smith,et al.  Course of psychiatric symptoms and global cognition in early Parkinson disease , 2014, Neurology.

[46]  F J Martinez-Murcia,et al.  Parametrization of textural patterns in 123I-ioflupane imaging for the automatic detection of Parkinsonism. , 2014, Medical physics.

[47]  R. Shadmehr,et al.  Motor Costs and the Coordination of the Two Arms , 2014, The Journal of Neuroscience.

[48]  Margaret Sutherland,et al.  Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study , 2015, The Lancet Neurology.

[49]  Olivier Gevaert,et al.  Core samples for radiomics features that are insensitive to tumor segmentation: method and pilot study using CT images of hepatocellular carcinoma , 2015, Journal of medical imaging.

[50]  M. Hatt,et al.  18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort , 2015, The Journal of Nuclear Medicine.

[51]  Jan Booij,et al.  The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review , 2015, EJNMMI Research.

[52]  Investigating the regional correlation of subcortical structures as imaged by DAT SPECT with clinical phenotypes in Parkinson’s disease , 2015 .

[53]  Reproducibility of F-18-FMISO intratumor distribution and texture features in NSCLC , 2015 .

[54]  A. Nordström,et al.  Depression and subsequent risk of Parkinson disease , 2015, Neurology.

[55]  Lakshminarayanan Samavedham,et al.  Unsupervised learning based feature extraction for differential diagnosis of neurodegenerative diseases: A case study on early-stage diagnosis of Parkinson disease , 2015, Journal of Neuroscience Methods.

[56]  J. Lee,et al.  Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality , 2015, American Journal of Neuroradiology.

[57]  Ivan S Klyuzhin,et al.  Exploring the use of shape and texture descriptors of positron emission tomography tracer distribution in imaging studies of neurodegenerative disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  Ronald Boellaard,et al.  Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation , 2016, Molecular Imaging and Biology.

[59]  Andrew Jackson,et al.  A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction , 2016, Physics in medicine and biology.

[60]  Junzhou Huang,et al.  IMAGING GENOMICS. , 2018, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.